Bg pattern

M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

M-M-RvaxPro

Powder and solvent for suspension for injection in a pre-filled syringe

Measles, mumps and rubella (live virus) vaccine

Read all of this leaflet carefully before you or your child is vaccinated because it contains important information for you or your child.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What M-M-RvaxPro is and what it is used for
  2. What you need to know before you receive M-M-RvaxPro
  3. How to use M-M-RvaxPro
  4. Possible side effects
  5. Storage of M-M-RvaxPro
  6. Contents of the pack and other information

1. What M-M-RvaxPro is and what it is used for

M-M-RvaxPro is a vaccine containing weakened viruses of measles, mumps and rubella. When the vaccine is given to a person, the immune system (the body’s natural defences) will create antibodies against the measles, mumps and rubella viruses. The antibodies help protect against infections caused by these viruses.

M-M-RvaxPro is given to help protect you or your child against measles, mumps and rubella. The vaccine can be given to people from 12 months of age onwards.

M-M-RvaxPro can also be given, in special circumstances, to children from 9 to 12 months of age.

M-M-RvaxPro may also be used during measles outbreaks, for post-exposure vaccination, or for use in people over 9 months of age who have not been previously vaccinated and are in contact with susceptible pregnant women, and people who are likely to be susceptible to mumps and rubella.

Although M-M-RvaxPro contains live viruses, they are too weak to cause measles, mumps or rubella in healthy individuals.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you receive M-M-RvaxPro

Do not use M-M-RvaxPro

Warnings and precautions

Tell your doctor or pharmacist before the person to be vaccinated receives M-M-RvaxPro if they have:

  • had an allergic reaction to egg or any egg-containing product.
  • a personal or family history of allergies or convulsions (fits).
  • had a side effect after measles, mumps and/or rubella vaccination that involved bruising or bleeding more than usual.
  • HIV infection without symptoms of HIV disease. The person to be vaccinated should be closely monitored during and after measles, mumps and rubella vaccination, which may be less effective than for uninfected individuals (see section Do not use M-M-RvaxPro).

As with other vaccines, M-M-RvaxPro may not completely protect all people who are vaccinated. Also, if the person to be vaccinated has already been exposed to measles, mumps or rubella virus but has not yet developed the disease, M-M-RvaxPro may not be able to prevent the disease from appearing.

M-M-RvaxPro can be given to people who have recently (within the last 3 days) been in contact with a case of measles and may be incubating the disease. However, in these cases, M-M-RvaxPro may not be able to prevent the development of measles.

Using M-M-RvaxPro with other medicines

Tell your doctor or pharmacist if the person to be vaccinated is using or has recently used other medicines (or other vaccines).

Your doctor may delay vaccination for at least 3 months after a blood or plasma transfusion or after the administration of immunoglobulin (known as Ig). After vaccination with M-M-RvaxPro, Ig should not be given for 1 month unless your doctor tells you otherwise.

If a tuberculin test is to be done, it should be done at any time before, at the same time as, or from 4 to 6 weeks after vaccination with M-M-RvaxPro.

M-M-RvaxPro can be given with a pneumococcal conjugate vaccine and/or a hepatitis A vaccine at the same time in different injection sites (e.g. the other arm or leg).

M-M-RvaxPro can be given with some routine infant vaccines as they may need to be given at the same time. For vaccines that cannot be given at the same time, M-M-RvaxPro should be given 1 month before or after administration of these vaccines.

Pregnancy and breast-feeding

M-M-RvaxPro should not be given to pregnant women. Women of childbearing age, after being vaccinated, should take precautions to avoid pregnancy for 1 month, or as advised by their doctor.

Tell your doctor if you are breast-feeding or are going to start breast-feeding. Your doctor will decide whether you should receive M-M-RvaxPro.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before receiving this vaccine.

Driving and using machines

There is no information to suggest that M-M-RvaxPro affects the ability to drive or use machines.

M-M-RvaxPro contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially “sodium-free”.

M-M-RvaxPro contains potassium

This medicine contains potassium, less than 1 mmol (39 mg) per dose; i.e. essentially “potassium-free”.

M-M-RvaxPro contains sorbitol (E-420)

This medicine contains 14.5 mg of sorbitol per dose. The additive effect of medicines containing sorbitol (or fructose) administered concomitantly and the intake of sorbitol (or fructose) from the diet should be taken into account.

3. How to use M-M-RvaxPro

M-M-RvaxPro should be injected into the muscle or under the skin in the outer aspect of the thigh or upper arm. For intramuscular injections, the thigh is the recommended site in young children, while the upper arm is the recommended site in older individuals. M-M-RvaxPro should not be injected into any blood vessel.

M-M-RvaxPro should be administered as follows:

A single dose on the selected date, normally from 12 months of age onwards. In special circumstances, it can be given from 9 months of age onwards. Additional doses should be administered according to the doctor’s recommendations. The interval between 2 doses should be at least 4 weeks.

Instructions for reconstitution intended for medical or healthcare professionals are included at the end of the package leaflet.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this vaccine can cause side effects, although not everybody gets them.

The following side effects were reported with the use of M-M-RvaxPro:

Frequency

Side effects

Very common (may affect more than 1 in 10 people)

  • Fever (38.5°C or higher).
  • Redness at the injection site, pain at the injection site and swelling at the injection site.

Common (may affect up to 1 in 10 people)

  • Rash (including measles-like rash).
  • Bruising at the injection site.

Uncommon (may affect up to 1 in 100 people)

  • Nasal congestion, sore throat, upper respiratory tract infection or viral infection, runny nose.
  • Crying.
  • Diarrhoea, vomiting.
  • Hives.
  • Rash at the injection site.

Frequency not known (cannot be estimated from the available data)*

  • Aseptic meningitis (fever, feeling unwell, vomiting, headache, stiff neck and sensitivity to light), swollen testicles, middle ear infection, swollen salivary glands, atypical measles (described in patients who received a killed measles virus vaccine, usually before 1975).
  • Swollen lymph nodes.
  • Bruising or bleeding more easily than usual.
  • Severe allergic reaction which may include difficulty breathing, facial swelling, localised swelling and swelling of the limbs.
  • Irritability.
  • Seizures (fits) without fever, seizures (fits) with fever in children, unsteady walking, dizziness, disease involving inflammation of the nervous system (brain and/or spinal cord).
  • Disease involving weakness of the muscles, abnormal sensations, tingling in the arms, legs and upper body (Guillain-Barré syndrome).
  • Headache, fainting, disorder of the nerves that can cause weakness, tingling or numbness, eye nerve disorders.
  • Discharge and itching in the eyes with crust formation on the eyelids (conjunctivitis).
  • Inflammation of the retina (in the eye) with changes in vision.
  • Deafness.
  • Cough, lung infection with or without fever.
  • Feeling sick (nausea).
  • Itching, inflammation of the fatty tissue under the skin, purple spots under the skin with the shape of a pinhead, skin spots, hardened and raised area of the skin, severe disease with ulcers or blisters on the skin, mouth, eyes and/or genitals (Stevens-Johnson syndrome).
  • Pain and/or swelling of the joints (usually transient and rarely chronic), muscle pain.
  • Burning and/or itching of short duration at the injection site, blisters and/or hives at the injection site.
  • General feeling of being unwell, swelling and pain.
  • Inflammation of blood vessels.
  • These side effects were reported with the administration of both M-M-RvaxPro and the measles, mumps and rubella vaccine manufactured by MSD as well as their monovalent (individual) components during post-marketing use and/or during clinical trials.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of M-M-RvaxPro

Keep out of the sight and reach of children.

Do not use this vaccine after the expiry date which is stated on the outer packaging after EXP. The expiry date refers to the last day of that month.

Store and transport refrigerated (between 2°C and 8°C).

Store the powder vial in the outer packaging to protect from light.

Do not freeze the vaccine.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Container contents and additional information

M-M-RvaxPro composition

The active ingredients are:

After reconstitution, a dose (0.5 ml) contains:

Measles virus1 Enders’ Edmonston strain (live, attenuated) not less than 1 x 10^3 TCID50*

Mumps virus1 Jeryl Lynn strain [Level B] (live, attenuated) not less than 12.5 x 10^3 TCID50*

Rubella virus2 Wistar RA 27/3 strain (live, attenuated) not less than 1 x 10^3 TCID50*

  • Dose that infects 50% of tissue cultures.

1 Produced in chicken embryo cells.

2 Produced in human diploid lung fibroblasts (WI-38).

The other components are:

Powder:

Sorbitol (E-420), sodium phosphate (NaH2PO4/Na2HPO4), potassium phosphate (KH2PO4/K2HPO4), sucrose, hydrolyzed gelatin, 199 medium with Hanks' salts, MEM, monosodium L-glutamate, neomycin, phenol red, sodium bicarbonate (NaHCO3), hydrochloric acid (HCl) (for pH adjustment) and sodium hydroxide (NaOH) (for pH adjustment).

Solvent:

Water for injections.

Appearance of M-M-RvaxPro and container contents

The vaccine is a powder for injectable suspension contained in a single-dose vial, which must be mixed with the supplied solvent.

The solvent is a clear, colorless liquid. The powder is a compact, crystalline mass of pale yellow color.

M-M-RvaxPro is available in packs of 1, 10, and 20, with or without needles. Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Merck Sharp & Dohme B.V., Waarderweg 39, 2031 BN Haarlem, Netherlands

For further information about this medicinal product, please contact the local representative of the marketing authorization holder.

België/Belgique/Belgien

MSD Belgium

Tel: +32(0)27766211

[email protected]

Lietuva

UAB Merck Sharp & Dohme

Tel. +370 5 2780 247

[email protected]

Text in Bulgarian language with contact information of Merck Sharp and Dohme Bulgaria, including phone and email

Luxembourg/Luxemburg

MSD Belgium

Tel: +32(0)27766211

[email protected]

Ceská republika

Merck Sharp & Dohme s.r.o.

Tel.: +420 233 010 111

[email protected]

Magyarország

MSD Pharma Hungary Kft.

Tel.: + 36.1.888.5300

[email protected]

Danmark

MSD Danmark ApS

Tlf.: + 45 4482 4000

[email protected]

Malta

Merck Sharp & Dohme Cyprus Limited.

Tel: 8007 4433 (+356 99917558)

[email protected]

Deutschland

MSD Sharp & Dohme GmbH

Tel: +49 (0) 89 20 300 4500

[email protected]

Nederland

Merck Sharp & Dohme B.V.

Tel: 0800 9999000

(+31 23 5153153)

[email protected]

Eesti

Merck Sharp & Dohme OÜ

Tel.: +372 6144 200

[email protected]

Norge

MSD (Norge) AS

Tlf: +47 32 20 73 00

[email protected]

Ελλάδα

MSD Α.Φ.Ε.Ε.

Τηλ: +30 210 98 97 300

[email protected]

Österreich

Merck Sharp & Dohme Ges.m.b.H.

Tel: +43 (0) 1 26 044

[email protected]

España

Merck Sharp & Dohme de España, S.A.

Tel: +34 91 321 06 00

[email protected]

Polska

MSD Polska Sp. z o.o.

Tel.: +48 22 549 51 00

[email protected]

France

MSD France

Tél: + 33 (0)1 80 46 40 40

Portugal

Merck Sharp & Dohme, Lda

Tel: +351 21 4465700

[email protected]

Hrvatska

Merck Sharp & Dohme d.o.o.

Tel: +385 1 66 11 333

[email protected]

România

Merck Sharp & Dohme Romania S.R.L

Tel: + 4021 529 29 00

[email protected]

Ireland

Merck Sharp & Dohme Ireland (Human Health) Limited

Tel: +353 (0)1 2998700

[email protected]

Slovenija

Merck Sharp & Dohme, inovativna zdravila d.o.o.

Tel: +386.1.520.4201

[email protected]

Ísland

Vistor hf.

Sími: + 354 535 7000

Slovenská republika

Merck Sharp & Dohme, s. r. o.

Tel: +421 2 58282010

[email protected]

Italia

MSD Italia S.r.l.

Tel: 800 23 99 89 (+39 06 361911)

[email protected]

Suomi/Finland

MSD Finland Oy

Puh/Tel: +358 (0)9 804 650

[email protected]

Κύπρος

Merck Sharp & Dohme Cyprus Limited

Τηλ: 800 00 673 (+357 22866700)

[email protected]

Sverige

Merck Sharp & Dohme (Sweden) AB

Tel: +46 77 5700488

[email protected]

Latvija

SIA Merck Sharp & Dohme Latvija

Tel.: +371 67025300

[email protected]

United Kingdom(Northern Ireland)

Merck Sharp & Dohme Ireland (Human Health) Limited

Tel: +353 (0)1 2998700

[email protected]

Date of last revision of this leaflet:<{MM/AAAA}><{month AAAA}>.

Other sources of information

Detailed information on this medicinal product is available on the European Medicines Agency website https://www.ema.europa.eu.

---------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

Before mixing with the solvent, the vaccine powder is a compact, crystalline mass of pale yellow color. The solvent is a clear, colorless liquid. When fully reconstituted, the vaccine is a clear yellow liquid.

For reconstitution of the vaccine, use the supplied solvent.

It is important to use a new sterile syringe and needle for each patient in order to prevent the transmission of infectious agents from one person to another.

A separate needle should be used for reconstitution and a different needle for injection.

Reconstitution instructions

To attach the needle, place it firmly on the syringe and secure it with a twist.

Inject the entire contents of the solvent from the syringe into the vial containing the powder. Gently swirl to mix completely.

The reconstituted vaccine should not be used if any foreign particles are observed or if the appearance of the solvent or powder or reconstituted vaccine differs from that described above.

After reconstitution, it is recommended to administer the vaccine immediately to minimize loss of potency or within 8 hours if stored in the refrigerator.

Do not freeze the reconstituted vaccine.

Withdraw the entire contents of the reconstituted vaccine from the vial into a syringe, change the needle, and inject the entire contents subcutaneously or intramuscularly.

Unused products or waste materials should be disposed of in accordance with local requirements.

See also section 3. How to use M-M-RvaxPro.

Online doctors for M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe

Discuss questions about M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€55
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€55
0.0 (0)
Doctor

Марта Регеро Капілья

Allergology 8 years exp.

Dr Marta Reguero Capilla is an allergist and immunologist who works with both adults and children. She specialises in the diagnosis, treatment, and ongoing management of allergic and immune-related conditions through online consultations.

In her practice, Dr Reguero Capilla helps patients understand the causes of their symptoms, review test results, and choose appropriate treatment or monitoring strategies. Her consultations are suitable both for first-time assessments and for follow-up care over time.

Patients commonly consult Dr Marta Reguero Capilla for:

  • allergic rhinitis, seasonal allergies, and perennial allergy symptoms;
  • allergic conditions in adults and children;
  • bronchial asthma and allergy-related respiratory symptoms;
  • urticaria (acute and chronic) and angioedema;
  • food allergies and reactions to foods, additives, or medications;
  • atopic dermatitis, allergic rashes, and persistent itching;
  • unexplained or recurrent allergic reactions;
  • interpretation of laboratory tests, allergy testing, and immunology results;
  • immune system concerns, frequent infections, and reduced immune response;
  • ongoing medical follow-up and treatment adjustment.
Dr Reguero Capilla works in a structured and attentive manner, explaining medical decisions clearly and helping patients make informed choices about their own health or their child’s care.

When clinically appropriate, she may provide recommendations for further tests or referrals that patients can use within Spanish medical networks, including Sanitas and DKV, in accordance with the terms and conditions of those services.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe?
M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe?
The active ingredient in M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe is measles, combinations with mumps and rubella, live attenuated. This information helps identify medicines with the same composition but different brand names.
Who manufactures M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe?
M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe is manufactured by Merck Sharp & Dohme B.V.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe?
Other medicines with the same active substance (measles, combinations with mumps and rubella, live attenuated) include M-M-RVAXPRO powder and solvent for injectable suspension, PRIORIX, POWDER AND SOLVENT FOR INJECTION IN PRE-FILLED SYRINGE, PROQUAD powder and solvent for injectable suspension in pre-filled syringe. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media